Clinical outcomes by Ad-NK4 administration will be influenced by dependence levels of mesothelioma on the HGF/c-Met pathway for the cell growth and on the angiogenesis which is produced by interactions between the tumors and the surrounding interstitial tissues. This evidence concerns the gene IL32 and mesothelioma.